SPINEGUARD SA (ALSGD.PA) Stock Fundamental Analysis

EPA:ALSGD • FR0011464452

0.1246 EUR
+0 (+1.3%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

1

Taking everything into account, ALSGD scores 1 out of 10 in our fundamental rating. ALSGD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. ALSGD may be in some trouble as it scores bad on both profitability and health. ALSGD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALSGD had negative earnings in the past year.
  • In the past year ALSGD has reported a negative cash flow from operations.
  • ALSGD had negative earnings in each of the past 5 years.
  • ALSGD had a negative operating cash flow in each of the past 5 years.
ALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFALSGD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

  • With a Return On Assets value of -30.70%, ALSGD is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
  • ALSGD has a Return On Equity of -59.83%. This is in the lower half of the industry: ALSGD underperforms 76.19% of its industry peers.
Industry RankSector Rank
ROA -30.7%
ROE -59.83%
ROIC N/A
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSGD.PA Yearly ROA, ROE, ROICALSGD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

  • With an excellent Gross Margin value of 70.98%, ALSGD belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
  • ALSGD's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALSGD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
ALSGD.PA Yearly Profit, Operating, Gross MarginsALSGD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ALSGD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALSGD has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALSGD has been increased compared to 5 years ago.
  • ALSGD has a worse debt/assets ratio than last year.
ALSGD.PA Yearly Shares OutstandingALSGD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ALSGD.PA Yearly Total Debt VS Total AssetsALSGD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -2.96, we must say that ALSGD is in the distress zone and has some risk of bankruptcy.
  • ALSGD has a Altman-Z score of -2.96. This is amonst the worse of the industry: ALSGD underperforms 82.54% of its industry peers.
  • ALSGD has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.34, ALSGD is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -2.96
ROIC/WACCN/A
WACC8.24%
ALSGD.PA Yearly LT Debt VS Equity VS FCFALSGD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • ALSGD has a Current Ratio of 1.07. This is a normal value and indicates that ALSGD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.07, ALSGD is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • ALSGD has a Quick Ratio of 1.07. This is a bad value and indicates that ALSGD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALSGD has a worse Quick ratio (0.82) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.82
ALSGD.PA Yearly Current Assets VS Current LiabilitesALSGD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 44.93% over the past year.
  • The Revenue has decreased by -4.47% in the past year.
  • The Revenue has been decreasing by -7.41% on average over the past years.
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.37%
Revenue 1Y (TTM)-4.47%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%-13.31%

3.2 Future

  • ALSGD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.42% yearly.
  • ALSGD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.70% yearly.
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue Next Year-27.83%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALSGD.PA Yearly Revenue VS EstimatesALSGD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ALSGD.PA Yearly EPS VS EstimatesALSGD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALSGD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSGD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSGD.PA Price Earnings VS Forward Price EarningsALSGD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSGD.PA Per share dataALSGD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALSGD's earnings are expected to grow with 29.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.36%
EPS Next 3Y29.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALSGD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SPINEGUARD SA

EPA:ALSGD (3/2/2026, 7:00:00 PM)

0.1246

+0 (+1.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-09
Earnings (Next)04-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.70M
Revenue(TTM)4.32M
Net Income(TTM)-2.56M
Analysts84.44
Price Target0.44 (253.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.75%
PT rev (3m)-31.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-14.69%
Revenue NY rev (3m)-14.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.71
P/FCF N/A
P/OCF N/A
P/B 2.73
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.05
BVpS0.05
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.7%
ROE -59.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.98%
FCFM N/A
ROA(3y)-32.05%
ROA(5y)-28.87%
ROE(3y)-64.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y-2.09%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.01%
Cap/Sales 5.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.82
Altman-Z -2.96
F-Score4
WACC8.24%
ROIC/WACCN/A
Cap/Depr(3y)225.04%
Cap/Depr(5y)170.18%
Cap/Sales(3y)14.39%
Cap/Sales(5y)11.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.37%
EPS Next Y83.22%
EPS Next 2Y35.36%
EPS Next 3Y29.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.47%
Revenue growth 3Y1.8%
Revenue growth 5Y-7.41%
Sales Q2Q%-13.31%
Revenue Next Year-27.83%
Revenue Next 2Y-7.32%
Revenue Next 3Y1.7%
Revenue Next 5YN/A
EBIT growth 1Y42.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.8%
EBIT Next 3Y22.07%
EBIT Next 5YN/A
FCF growth 1Y65.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.2%
OCF growth 3YN/A
OCF growth 5YN/A

SPINEGUARD SA / ALSGD.PA FAQ

Can you provide the ChartMill fundamental rating for SPINEGUARD SA?

ChartMill assigns a fundamental rating of 1 / 10 to ALSGD.PA.


What is the valuation status for ALSGD stock?

ChartMill assigns a valuation rating of 1 / 10 to SPINEGUARD SA (ALSGD.PA). This can be considered as Overvalued.


Can you provide the profitability details for SPINEGUARD SA?

SPINEGUARD SA (ALSGD.PA) has a profitability rating of 1 / 10.


How financially healthy is SPINEGUARD SA?

The financial health rating of SPINEGUARD SA (ALSGD.PA) is 1 / 10.